28
Oct
2025

Pharmathen SA

Exhibitor at CPHI Frankfurt 2025 stand 3.0C52, Finished Dosage Formulations
About Us

We develop complex drug delivery and formulations to enhance patient compliance and offer affordable, high-quality medicines globally. We serve 250+ customers across 90+ countries globally including Europe, North America, South America, Middle East & North Africa, Asia-Pacific. Our portfolio includes over 100 products: Finished Dosages (including long-acting injectables, peptides, modified-release orals, other complex ophthalmics and injectables); & APIs (peptides and others). All products are manufactured in FDA and EU-approved GMP facilities.

  • GR
  • 2015
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Generic APIs producer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Technology
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.0C52, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Products

    Product Products

    Please follow the following link to view our Product Catalogues:
    https://www.pharmathen.com/portfolio
    Contact us for more information.